Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Adrenergic receptor beta-3 (ADRB3) |
Target Info
|
Agonist |
[1] |
| Cyclin-dependent kinase 1 (CDK1) |
Target Info
|
Binder |
[2] |
| Cyclin-dependent kinase 2 (CDK2) |
Target Info
|
Inhibitor |
[3] |
| Cyclin-dependent kinase 5 (CDK5) |
Target Info
|
Inhibitor |
[3] |
| References |
Top |
| REF 1 |
Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.
|
| REF 2 |
Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. J Biol Chem. 2004 May 7;279(19):20267-76.
|
| REF 3 |
Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci. 2002 Sep;23(9):417-25.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
